Table of Contents Author Guidelines Submit a Manuscript
Volume 2015, Article ID 354737, 7 pages
Research Article

Anemia in Patients with Type 2 Diabetes Mellitus

1Regional University of Northwestern Rio Grande do Sul (UNIJUÍ), Ijuí, RS, Brazil
2Program in Respiratory Sciences, the Federal University of Rio Grande do Sul (UFRGS), Porto Alegre, RS, Brazil
3Department of Life Sciences, the Regional University of Northwestern Rio Grande do Sul (UNIJUÍ), Rua do Comércio No. 3000, Bairro Universitário, 98700 000 Ijuí, RS, Brazil
4Program in Integral Attention to Health (PPGAIS-UNIJUI/UNICRUZ), Ijuí, RS, Brazil
5Program in Pharmacology of the Health Sciences Center, The Federal University of Santa Maria (UFSM), RS, Brazil
6Cenecista Institute for Higher Education, Rua Dr. João Augusto Rodrigues 471, 98801 015 Santo Ângelo, RS, Brazil

Received 30 June 2015; Revised 7 September 2015; Accepted 13 September 2015

Academic Editor: Eitan Fibach

Copyright © 2015 Jéssica Barbieri et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


The objective of this study was to evaluate the prevalence of anemia in DM2 patients and its correlation with demographic and lifestyle and laboratory variables. This is a descriptive and analytical study of the type of case studies in the urban area of the Ijuí city, registered in programs of the Family Health Strategy, with a total sample of 146 patients with DM2. A semistructured questionnaire with sociodemographic and clinical variables and performed biochemical test was applied. Of the DM2 patients studied, 50 patients had anemia, and it was found that the body mass items and hypertension and hematological variables are significantly associated with anemia of chronic disease. So, the prevalence of anemia is high in patients with DM2. The set of observed changes characterizes the anemia of chronic disease, which affects quality of life of diabetic patients and is associated with disease progression, development, and comorbidities that contribute significantly to increasing the risk of cardiovascular diseases.